Report Summary
Eternity Insights has published a new study on Global Real-time PCR (qPCR) And Digital PCR (dPCR) Market focusing on key segments as by Type (Consumables & Reagents,Instruments,Software & Services, Other), by Application (Clinical,Research,Forensic and others, Other), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Real-time PCR (qPCR) And Digital PCR (dPCR) Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Real-time PCR (qPCR) And Digital PCR (dPCR) Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Real-time PCR (qPCR) And Digital PCR (dPCR) Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Real-time PCR (qPCR) And Digital PCR (dPCR) Market Segmentation:
Real-time PCR (qPCR) And Digital PCR (dPCR) Market, By Type
- Consumables & Reagents
- Instruments
- Software & Services
- Other
Real-time PCR (qPCR) And Digital PCR (dPCR) Market, By Application
- Clinical
- Research
- Forensic and others
- Other
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Real-time PCR (qPCR) And Digital PCR (dPCR) market in terms of demand generation. The Real-time PCR (qPCR) And Digital PCR (dPCR) market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Real-time PCR (qPCR) And Digital PCR (dPCR) market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Real-time PCR (qPCR) And Digital PCR (dPCR) Market Taxonomy:
To learn more about this report
Global Real-time PCR (qPCR) And Digital PCR (dPCR) Market Competitive Landscape
The global Real-time PCR (qPCR) And Digital PCR (dPCR) market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories
- Inc.
- QIAGEN
- Abbott
- Cepheid
- Agilent Technologies
- GE Healthcare
- bioM�rieux SA
- F. Hoffmann-La Roche Ltd
- Fluidigm Corporation
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Consumables & Reagents,Instruments,Software & Services, Other |
| By Application Outlook |
Clinical,Research,Forensic and others, Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Thermo Fisher Scientific Inc.,Bio-Rad Laboratories, Inc.,QIAGEN, Abbott,Cepheid, Agilent Technologies,GE Healthcare,bioM�rieux SA,F. Hoffmann-La Roche Ltd,Fluidigm Corporation |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
Global Real-time PCR (qPCR) and Digital PCR (dPCR) Market by Manufacturers, Regions, Type and Application, Forecast to 2026
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Real-time PCR (qPCR) and Digital PCR (dPCR) Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Assessment by Type
2.1 Consumables & Reagents Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.2 Instruments Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.3 Software & Services Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
3 Asia Pacific Real-time PCR (qPCR) and Digital PCR (dPCR) Market Assessment by Type
3.1 Asia Pacific Market Performance (Sales, Revenue)
3.2 Key Players in Asia Pacific
4 North America Real-time PCR (qPCR) and Digital PCR (dPCR) Market Assessment by Type
4.1 North America Market Performance (Sales, Revenue)
4.2 Key Players in North America
5 Europe Real-time PCR (qPCR) and Digital PCR (dPCR) Market Assessment by Type
4.1 Europe Market Performance (Sales, Revenue)
4.2 Key Players in Europe
6 South America Real-time PCR (qPCR) and Digital PCR (dPCR) Market Assessment by Type
4.1 South America Market Performance (Sales, Revenue)
4.2 Key Players in South America
7 Middle Easr and Africa Real-time PCR (qPCR) and Digital PCR (dPCR) Market Assessment by Type
4.1 Middle Easr and Africa Market Performance (Sales, Revenue)
4.2 Key Players in Middle Easr and Africa
8 World Real-time PCR (qPCR) and Digital PCR (dPCR) Market Assessment by Type
8.1 Asia Pacific Real-time PCR (qPCR) and Digital PCR (dPCR) Market Assessment by Application (Consumption and Market Share)
8.2 North America Real-time PCR (qPCR) and Digital PCR (dPCR) Market Assessment by Application (Consumption and Market Share)
8.3 Europe Real-time PCR (qPCR) and Digital PCR (dPCR) Market Assessment by Application (Consumption and Market Share)
8.4 South America Real-time PCR (qPCR) and Digital PCR (dPCR) Market Assessment by Application (Consumption and Market Share)
8.5 Middle East and Africa Real-time PCR (qPCR) and Digital PCR (dPCR) Market Assessment by Application (Consumption and Market Share)
9 Company Profiles/Analysis
9.1 Thermo Fisher Scientific Inc.
9.1.1 Thermo Fisher Scientific Inc. Profiles
9.1.2 Thermo Fisher Scientific Inc. Product Portfolio
9.1.3 Thermo Fisher Scientific Inc. Real-time PCR (qPCR) and Digital PCR (dPCR) Business Performance
9.1.4 Thermo Fisher Scientific Inc. Real-time PCR (qPCR) and Digital PCR (dPCR) Business Development and Market Status
9.2 Bio-Rad Laboratories, Inc.
9.2.1 Bio-Rad Laboratories, Inc. Profiles
9.2.2 Bio-Rad Laboratories, Inc. Product Portfolio
9.2.3 Bio-Rad Laboratories, Inc. Real-time PCR (qPCR) and Digital PCR (dPCR) Business Performance
9.2.4 Bio-Rad Laboratories, Inc. Real-time PCR (qPCR) and Digital PCR (dPCR) Business Development and Market Status
9.3 QIAGEN, Abbott
9.3.1 QIAGEN, Abbott Profiles
9.3.2 QIAGEN, Abbott Product Portfolio
9.3.3 QIAGEN, Abbott Real-time PCR (qPCR) and Digital PCR (dPCR) Business Performance
9.3.4 QIAGEN, Abbott Real-time PCR (qPCR) and Digital PCR (dPCR) Business Development and Market Status
9.4 Cepheid, Agilent Technologies
9.4.1 Cepheid, Agilent Technologies Profiles
9.4.2 Cepheid, Agilent Technologies Product Portfolio
9.4.3 Cepheid, Agilent Technologies Real-time PCR (qPCR) and Digital PCR (dPCR) Business Performance
9.4.4 Cepheid, Agilent Technologies Real-time PCR (qPCR) and Digital PCR (dPCR) Business Development and Market Status
9.5 GE Healthcare
9.5.1 GE Healthcare Profiles
9.5.2 GE Healthcare Product Portfolio
9.5.3 GE Healthcare Real-time PCR (qPCR) and Digital PCR (dPCR) Business Performance
9.5.4 GE Healthcare Real-time PCR (qPCR) and Digital PCR (dPCR) Business Development and Market Status
9.6 bioMérieux SA
9.6.1 bioMérieux SA Profiles
9.6.2 bioMérieux SA Product Portfolio
9.6.3 bioMérieux SA Real-time PCR (qPCR) and Digital PCR (dPCR) Business Performance
9.6.4 bioMérieux SA Real-time PCR (qPCR) and Digital PCR (dPCR) Business Development and Market Status
9.7 F. Hoffmann-La Roche Ltd
9.7.1 F. Hoffmann-La Roche Ltd Profiles
9.7.2 F. Hoffmann-La Roche Ltd Product Portfolio
9.7.3 F. Hoffmann-La Roche Ltd Real-time PCR (qPCR) and Digital PCR (dPCR) Business Performance
9.7.4 F. Hoffmann-La Roche Ltd Real-time PCR (qPCR) and Digital PCR (dPCR) Business Development and Market Status
9.8 Fluidigm Corporation
9.8.1 Fluidigm Corporation Profiles
9.8.2 Fluidigm Corporation Product Portfolio
9.8.3 Fluidigm Corporation Real-time PCR (qPCR) and Digital PCR (dPCR) Business Performance
9.8.4 Fluidigm Corporation Real-time PCR (qPCR) and Digital PCR (dPCR) Business Development and Market Status
10 World Real-time PCR (qPCR) and Digital PCR (dPCR) Market Assessment by Players
10.1 Global Real-time PCR (qPCR) and Digital PCR (dPCR) Sales (K Units) and Market Share by Players 2014-2020
10.2 Global Real-time PCR (qPCR) and Digital PCR (dPCR) Revenue (M USD) and Market Share by Players 2014-2020
10.3 Global Real-time PCR (qPCR) and Digital PCR (dPCR) Price (USD/Unit) of Players 2014-2020
10.4 Global Real-time PCR (qPCR) and Digital PCR (dPCR) Gross Margin of Players 2014-2020
10.5 Market Concentration
11 Regional Market Performance by Segment of Players
11.1 North America
11.1.1 North America Real-time PCR (qPCR) and Digital PCR (dPCR) Sales Assessment of Players 2014-2020
11.1.2 North America Real-time PCR (qPCR) and Digital PCR (dPCR) Revenue Assessment of Players 2014-2020
11.1.3 North America Real-time PCR (qPCR) and Digital PCR (dPCR) Price Assessment of Players 2014-2020
11.1.4 North America Real-time PCR (qPCR) and Digital PCR (dPCR) Gross Margin Assessment of Players 2014-2020
11.1.5 Market Concentration
11.2 Europe
11.2.1 Europe Real-time PCR (qPCR) and Digital PCR (dPCR) Sales Assessment of Players 2014-2020
11.2.2 Europe Real-time PCR (qPCR) and Digital PCR (dPCR) Revenue Assessment of Players of Manufacturers 2014-2020
11.2.3 Europe Real-time PCR (qPCR) and Digital PCR (dPCR) Price Assessment of Players 2014-2020
11.2.4 Europe Real-time PCR (qPCR) and Digital PCR (dPCR) Gross Margin Assessment of Players 2014-2020
11.2.5 Market Concentration
11.3 Asia-Pacific Market Performance for Manufacturers
11.3.1 Asia-Pacific Real-time PCR (qPCR) and Digital PCR (dPCR) Sales Assessment of Players 2014-2020
11.3.2 Asia-Pacific Real-time PCR (qPCR) and Digital PCR (dPCR) Revenue Assessment of Players 2014-2020
11.3.3 Asia-Pacific Real-time PCR (qPCR) and Digital PCR (dPCR) Price Assessment of Players 2014-2020
11.3.4 Asia-Pacific Real-time PCR (qPCR) and Digital PCR (dPCR) Gross Margin Assessment of Players 2014-2020
11.3.5 Market Concentration
11.4 South America Market Performance for Players
11.4.1 South America Real-time PCR (qPCR) and Digital PCR (dPCR) Sales Assessment of Players 2014-2020
11.4.2 South America Real-time PCR (qPCR) and Digital PCR (dPCR) Revenue Assessment of Players 2014-2020
11.4.3 South America Real-time PCR (qPCR) and Digital PCR (dPCR) Price Assessment of Players 2014-2020
11.4.4 South America Real-time PCR (qPCR) and Digital PCR (dPCR) Gross Margin Assessment of Players 2014-2020
11.4.5 Market Concentration
11.5 Middle East and Africa Market Performance for Players
11.5.1 Middle East and Africa Real-time PCR (qPCR) and Digital PCR (dPCR) Sales Assessment of Players 2014-2020
11.5.2 Middle East and Africa Real-time PCR (qPCR) and Digital PCR (dPCR) Revenue Assessment of Players 2014-2020
11.5.3 Middle East and Africa Real-time PCR (qPCR) and Digital PCR (dPCR) Price Assessment of Players 2014-2020
11.5.4 Middle East and Africa Real-time PCR (qPCR) and Digital PCR (dPCR) Gross Margin Assessment of Players 2014-2020
11.5.5 Market Concentration
12 Regional Market Performance by Segment of Countries
12.1 Asia Pacific
12.1.1 Asia Pacific Real-time PCR (qPCR) and Digital PCR (dPCR) Sales by Countries/Regions 2014-2020
12.1.2 Asia Pacific Real-time PCR (qPCR) and Digital PCR (dPCR) Revenue by Countries/Regions 2014-2020
12.1.3 Asia Pacific Real-time PCR (qPCR) and Digital PCR (dPCR) Average Price by Countries/Regions 2014-2020
12.2 North America
12.2.1 North America Real-time PCR (qPCR) and Digital PCR (dPCR) Sales by Countries/Regions 2014-2020
12.2.2 North America Real-time PCR (qPCR) and Digital PCR (dPCR) Revenue by Countries/Regions 2014-2020
12.2.3 North America Real-time PCR (qPCR) and Digital PCR (dPCR) Average Price by Countries/Regions 2014-2020
12.3 Europe
12.3.1 Europe Real-time PCR (qPCR) and Digital PCR (dPCR) Sales by Countries/Regions 2014-2020
12.3.2 Europe Real-time PCR (qPCR) and Digital PCR (dPCR) Revenue by Countries/Regions 2014-2020
12.3.3 Europe Real-time PCR (qPCR) and Digital PCR (dPCR) Average Price by Countries/Regions 2014-2020
12.4 South America
12.4.1 South America Real-time PCR (qPCR) and Digital PCR (dPCR) Sales by Countries/Regions 2014-2020
12.4.2 South America Real-time PCR (qPCR) and Digital PCR (dPCR) Revenue by Countries/Regions 2014-2020
12.4.3 South America Real-time PCR (qPCR) and Digital PCR (dPCR) Average Price by Countries/Regions 2014-2020
12.5 Middle East and Africa
12.5.1 Middle East and Africa Real-time PCR (qPCR) and Digital PCR (dPCR) Sales by Countries/Regions 2014-2020
12.5.2 Middle East and Africa Real-time PCR (qPCR) and Digital PCR (dPCR) Revenue by Countries/Regions 2014-2020
12.5.3 Middle East and Africa Real-time PCR (qPCR) and Digital PCR (dPCR) Average Price by Countries/Regions 2014-2020
13 Technology and Opportunity
13.1 Technology
13.2 Market Opportunity
14 World Real-time PCR (qPCR) and Digital PCR (dPCR) Sales & Revenue Forecast 2021-2026
14.1 World Real-time PCR (qPCR) and Digital PCR (dPCR) Sales and Revenue Forecast by Regions 2021-2026
14.1.1 World Real-time PCR (qPCR) and Digital PCR (dPCR)Sales and Market Share by Regions
14.1.2 World Real-time PCR (qPCR) and Digital PCR (dPCR)Revenue and Market Share by Regions
15 Asia Real-time PCR (qPCR) and Digital PCR (dPCR) Market Forecast 2021-2026
15.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
15.1.1 Consumables & Reagents
15.1.2 Instruments
15.1.3 Software & Services
15.2 Consumption Forecast by Application, 2021-2026
16 North America Real-time PCR (qPCR) and Digital PCR (dPCR) Market Forecast 2021-2026
16.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
16.1.1 Consumables & Reagents
16.1.2 Instruments
16.1.3 Software & Services
16.2 Consumption Forecast by Application, 2021-2026
17 Europe Real-time PCR (qPCR) and Digital PCR (dPCR) Market Forecast 2021-2026
17.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
17.1.1 Consumables & Reagents
17.1.2 Instruments
17.1.3 Software & Services
17.2 Consumption Forecast by Application, 2021-2026
18 South America Real-time PCR (qPCR) and Digital PCR (dPCR) Market Forecast 2021-2026
18.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
18.1.1 Consumables & Reagents
18.1.2 Instruments
18.1.3 Software & Services
18.2 Consumption Forecast by Application, 2021-2026
19 Middle East and Africa Real-time PCR (qPCR) and Digital PCR (dPCR) Market Forecast 2021-2026
19.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
19.1.1 Consumables & Reagents
19.1.2 Instruments
19.1.3 Software & Services
19.2 Consumption Forecast by Application, 2021-2026
20 Price (USD/Unit) and Gross Profit Forecast
20.1 Global Real-time PCR (qPCR) and Digital PCR (dPCR) Price (USD/Unit) Trend 2021-2026
20.2 Global Real-time PCR (qPCR) and Digital PCR (dPCR) Gross Profit Trend 2021-2026
21 Conclusion
